GLP-1 Hair Loss: The Risk Nobody Warned You About
People taking GLP-1 medications — the class that includes Ozempic, Wegovy, Mounjaro — carry a meaningfully higher risk of hair loss compared to people on other diabetes medications.
GLP-1 Hair Loss: The Risk Nobody Warned You About
There is a particular kind of vanity that health journalism rarely dignifies — the one that sits in front of a mirror six months into a medication and notices, quietly, that something has changed. Not dramatically. Not all at once. Just a little more on the brush than usual. A little more at the drain.
New research has given that quiet observation a number. People taking GLP-1 medications — the class that includes Ozempic, Wegovy, Mounjaro — carry a meaningfully higher risk of hair loss compared to people on other diabetes medications. The absolute risk remains low. But "low" is doing a lot of work in that sentence, and the study's authors were careful not to let it do too much.
What seems to be happening is partly physiological and partly mechanical. Rapid weight loss — which is precisely what these drugs are designed to produce — is a known trigger for a condition called telogen effluvium, where the hair cycle is disrupted by the metabolic shock of losing body mass quickly. The hair follicle interprets sudden caloric deficit the way it interprets other stressors: it pauses. It waits. And while it waits, the shaft falls out.
This is almost always temporary. That matters. The follicle is not damaged; it is dormant. In most documented cases, regrowth follows once the body stabilises at its new weight and the metabolic stress recedes. But temporary can mean six months, and six months is a long time to watch something leave you without knowing when it plans to return.
What the research also implies — though it stops short of proving — is that the speed of loss may be more responsible than the drug itself. Which means that the people most at risk are the people losing weight fastest. Which is often the point.
There are practical interventions that matter here. Protein intake is the first one — hair is keratin, keratin is protein, and people on appetite-suppressing medications frequently under-eat protein without realising it. The target for most adults is around 1.2 to 1.6 grams per kilogram of body weight per day, and it is remarkably easy to fall short when your appetite has been pharmaceutically reduced. Iron levels are the second variable — ferritin in particular, which is the stored form, and which drops before standard haemoglobin levels signal anything unusual. If you are on a GLP-1 and you are losing hair, ask your doctor to check your ferritin. Not just your iron. Your ferritin.
The third thing — less clinical, but no less real — is to not panic. The body under change is not a body failing. It is a body recalibrating.
One thing for tomorrow: If you take a GLP-1 or are considering one, track your daily protein. Not obsessively — just honestly. One week of data is enough to know whether you are hitting your range or quietly falling short of it.
